Perspective

The NhLBI STraTegIc VISIoN
The National Heart, Lung, and Blood Institute (NHLBI) has provided global leadership for scientific research advances that have fueled remarkable health gains for nearly 70 years. To build on this legacy and chart a course for future research over the next decade, NHLBI initiated an unprecedented strategic visioning process that engaged diverse stakeholders from across the United States and around the globe. 1 The resulting Strategic Vision has four mission-oriented goals that guide research opportunities and eight strategic objectives. 2 As shown in Figure 1 , the four goals include: 1) the molecular, cellular, and physiological mechanisms governing normal function in heart, lung, blood, and sleep (HLBS) health; 2) the pathobiological basis of HLBS diseases and disorders; 3) research translation across the entire research spectrum from fundamental basic discoveries to population health impact; and 4) the development of a diverse biomedical workforce. Figure 1 also shows the eight strategic objectives that reflect one or more of the four mission-oriented strategic goals and generally explore both biological and non-biological contributors to health and disease. 2
The NhLBI ceNTer for TraNSLaTIoN reSearch aNd ImpLemeNTaTIoN ScIeNce
The Center for Translation Research and Implementation Science (CTRIS) at NHLBI serves as a strategic focal point for advancing late-stage (T4) translation research, which focuses on population-level outcomes, 3 and implementation science in alignment with the NHLBI Strategic Vision. Additionally, CTRIS addresses health inequities research, global health research, and workforce development in HLBS diseases and disorders. This perspective highlights related aspects of the Strategic Vision within the core mission areas of CTRIS that may be of particular interest to clinical and public health researchers.
Increasingly, it has become recognized that the remarkable successes demonstrated in fundamental discovery science and early-stage translational research stand in sharp contrast to the limited findings from late-stage translational research, especially the T4 phase. 4 One contributing barrier creating this limitation is the lack leverage stakeholders at the convergence of implementation science, precision medicine, and the learning health care system will be invaluable. 5 Opportunities that facilitate the rigorous design, execution, and evaluation of large, relatively inexpensive pragmatic trials in the adoption, scale-up, and spread of proven-effective interventions hold great promise. Although rigorous systematic evidence reviews and trustworthy clinical guidelines exist, adherence from patient and provider perspectives remains suboptimal. In addition, few studies have used validated implementation frameworks and outcomes to assess strategies for improving guideline adherence, scale-up, and sustainment for the prevention and treatment of HLBS disorders, or for de-implementation of ineffective, unproven, or outdated practices. The Strategic Vision recognizes these challenges as priorities for clinical and public health research and focuses its vision on four areas: health inequities research; global health research; research and training of a diverse scientific workforce; and maximizing population health impact, as we describe below.
Health Inequities Research
Despite notable improvements in the overall health of the United States during the past half-century, health inequities have persisted. 6 There is a critical need to advance health inequities research in HLBS diseases and disorders such as hypertension, asthma, chronic lung disease, and sickle cell disease. At the same time, a growing interest has emerged to tackle the rising burden of HLBS diseases and disorders as comorbidities of HIV infection. Community-engaged research, aligned with community needs and priorities, facilitates the adoption and translation of research findings to maximize health impact. Importantly, implementation and scale-up of evidencebased strategies and approaches also have the potential to reduce disparities in health outcomes in populations in the United States and across the globe.
Global Health Research
Compelling evidence suggests that, in aggregate, health is improving across the globe with dramatic declines in mortality and morbidity in high-income countries but not in many low-and middle-income countries (LMICs). 7 The NHLBI seeks to support innovative research that has the potential to reduce the burden of HLBS diseases in LMICs. 8 T4 translation research conducted in LMICs offers unique opportunities to understand key barriers in the adoption, scale-up and sustainment of evidence-based interventions valuable in LMICs as well as in low-resource settings in high-income countries. Research that galvanizes patients, non-governmental organizations, academia and ministries of health and finance together has the potential to find sustainable solutions tailored to context. Similarly, research partnerships with key national and international organizations, such as the World Health Organization (WHO), expand the knowledge base for adoption, adaptation, dissemination, and scale-up of best practices and attract valuable investments in global health programming. 9
Research Training and Development of a Diverse Scientific Workforce
The Strategic Vision recognizes that basic, clinical, and translational research sustained implementation of proveneffective interventions. Similarly, research to advance de-implementation of practices that provide little or no added value and the timely progression from discovery to implementation, scale-up, and spread of effective interventions aligns strongly with the NHLBI Strategic Vision and objectives. 2 The Strategic Vision also underscores the importance of team science that advances synergy among diverse professionals from biomedical, behavioral, and social science research as well as experts from engineering, bioinformatics, behavioral economics, and the emerging field of big data science. Strategies that training efforts are still often performed in isolation or within silos based on specific diseases or disciplines, lacking collaboration or a productive team science approach. Emerging implementation research competencies using state-ofthe-art frameworks in cultural contexts will be important to address both do-mestic and global health research workforce needs. Developing a cadre of T4 translation researchers will require transdisciplinary mentoring approaches that 
Maximizing Population Health Impact
We are poised to maximize the population-level impact of turning research discoveries into improved health outcomes. Maximizing population health impact of these research discoveries is highly feasible through the strategic priorities described here for implementation science, health inequities research, global research, and research training. The NHLBI looks forward to active engagement of clinical, public health, and the entire scientific research community as we chart the future for latestage (T4) translation research and implementation science to maximize population health impact on HLBS diseases, disorders, and related disparities in the United States and abroad.
coNcLuSIoNS
The four mission-driven goals and eight strategic objectives of the NHLBI Strategic Vision set the research agenda and provide a framework for advancing research in HLBS diseases and disorders through 2025. The strategic vision also provides an opportunity to advance an evidence-based elimination of health inequities in HLBS diseases and disorders. As the strategic focal point at NHLBI to accelerate the process of turning discovery science into health impact, CTRIS stands ready and committed to work with biomedical, behavioral, and social science research investigators as well as dissemination and implementation researchers to help execute the NHLBI Strategic Vision. We look forward to working with the full spectrum of basic, clinical, translational, and population science investigators as well as strategic partners in the public health research community as we chart our future together over the next decade. 
